RSS - Subscribe to the News Today on Proactive AU ▼
Imugene will divest Linguet™ to focus on HER-Vaxx, one of the world’s most advanced B cell vaccines. Her-Vaxx has potential to improve upon Roche’s blockbuster Herceptin drug that generated annualised sales of $6.9B and targets the same biomarker.
RSS - Subscribe to the News Today on Proactive NA ▼
Canadian stocks dropped for a second day, driven by energy producers, after OPEC decided not to trim production and oil prices tumbled to a four-and-a-half year low.
RSS - Subscribe to the News Today on Proactive CN ▼
Crude oil prices sank to a four-and-a-half year low after the Organization of Petroleum Exporting Countries (OPEC) stopped short from reducing production limits. West Texas Intermediate for [...]